Clinical Trial Update: Palbociclib and Pembrolizumab in Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial of palbociclib in combination with pembrolizumab for sarcoma is currently recruiting, sponsored by John Rieth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• IBRANCE (PALBOCICLIB)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: John Rieth | Conditions: Sarcoma | Phase 1 | Status: RECRUITING